Lantheus Holdings, Inc. (LNTH)
77.41
+1.11
(+1.45%)
USD |
NASDAQ |
Mar 03, 13:19
Lantheus Holdings Research and Development Expense (Annual) : 177.31M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Align Technology, Inc. | 369.91M |
| Anika Therapeutics, Inc. | 25.77M |
| BioCryst Pharmaceuticals, Inc. | 164.74M |
| The Cooper Cos., Inc. | 172.20M |
| Iovance Biotherapeutics, Inc. | 300.27M |